Miller Anestesia

57. Malinovsky JM, Cozian A, Lepage JY, et al: Keta-

mine and midazolam neurotoxicity in the rabbit.

Anesthesiology 75:91–97, 1991.

58. Petroz GC, Sikich N, James M, et al: A phase I, two-

center study of the pharmacokinetics and pharma-

codynamics of dexmedetomidine in children.

Anesthesiology 105:1098–1110, 2006.

59. Tosun Z, Akin A, Guler G, et al: Dexmedetomidine-

ketamine and propofol-ketamine combinations for

anesthesia in spontaneously breathing pediatric

patients undergoing cardiac catheterization. J Car-

diothorac Vasc Anesth 20:515–519, 2006.

60. Munro HM, Tirotta CF, Felix DE, et al: Initial expe-

rience with dexmedetomidine for diagnostic and

interventional cardiac catheterization in children.

Paediatr Anaesth 17:109–112, 2007.

61. Luscri N, Tobias JD: Monitored anesthesia care with

a combination of ketamine and dexmedetomidine

during magnetic resonance imaging in three chil-

dren with trisomy 21 and obstructive sleep apnea.

Paediatr Anaesth 16:782–786, 2006.

62. Koroglu A, Teksan H, Sagir O, et al: A comparison

of the sedative, hemodynamic, and respiratory

effects of dexmedetomidine and propofol in chil-

dren undergoing magnetic resonance imaging.

Anesth Analg 103:63–67, 2006.

63. MasonKP,ZgleszewskiSE,DeardenJL

,etal:Dexmede

tomidine for pediatric sedation for computed tomogra-

phy imaging studies. Anesth Analg 103:57–62, 2006.

64. Zub D, Berkenbosch JW, Tobias JD: Preliminary

experience with oral dexmedetomidine for proce-

dural and anesthetic premedication. Paediatr

Anaesth 15:932–938, 2005.

65. Jooste EH, Ohkawa S, Sun LS: Fiberoptic intubation

with dexmedetomidine in two children with spinal

cord impingements. Anesth Analg 101:1248, 2005.

66. Everett LL, van Rooyen IF, Warner MH, et al: Use of

dexmedetomidine in awake craniotomy in adoles-

cents: Report of two cases. Paediatr Anaesth

16:338–342, 2006.

67. Shukry M, Clyde MC, Kalarickal PL, Ramadhyani

U: Does dexmedetomidine prevent emergence deli-

rium in children after sevoflurane-based general

anesthesia? Paediatr Anaesth 15:1098–1104, 2005.

68. Isik B, Arslan M, Tunga AD, Kurtipek O: Dexmede-

tomidine decreases emergence agitation in pedia-

tric patients after sevoflurane anesthesia without

surgery. Paediatr Anaesth 16:748–753, 2006.

69. Finkel JC, Johnson YJ, Quezado ZM: The use of

dexmedetomidine to facilitate acute discontinua-

tion of opioids after cardiac transplantation in chil-

dren. Crit Care Med 33:2110–2112, 2005.

70. Hammer GB, Philip BM, Schroeder AR, et al: Pro-

longed infusion of dexmedetomidine for sedation

following tracheal resection. Paediatr Anaesth

15:616–620, 2005.

71. Kupferberg HJ, Way HJ: Pharmacologic basis for the

increased sensitivity of the newborn to morphine. J

Pharmacol Exp Ther 141:105–109, 1963.

72. Lynn AM, Slattery JT: Morphine pharmacokinetics

in early infancy. Anesthesiology 66:136–139, 1987.

73. Bragg P, Zwass MS, Lau M, Fisher DM: Opioid phar-

macodynamics in neonatal dogs: Differences

between morphine and fentanyl. J Appl Physiol

79:1519–1524, 1995.

74. Way WL, Costley EC, Way EI: Respiratory sensiti-

vity of the newborn infant to meperidine and mor-

phine. Clin Pharmacol Ther 6:454–461, 1965.

75. Yaster M: The dose response of fentanyl in neonatal

anesthesia. Anesthesiology 66:433–435, 1987.

76. Kuhls E, Gauntlett IS, Lau M, et al: Effect of increa-

sed intra-abdominal pressure on hepatic extraction

and clearance of fentanyl in neonatal lambs. J Phar-

macol Exp Ther 274:115–119, 1995.

77. Starr NJ, Sethna DH, Estafanous FG: Bradycardia

and asystole following the rapid administration of

sufentanil with vecuronium. Anesthesiology

64:521–523, 1986.

78. Davis PJ, Lerman J, Suresh S, et al: A randomized

multicenter study of remifentanil compared with

alfentanil, isoflurane, or propofol in anesthetized

pediatric patients undergoing elective strabismus

surgery. Anesth Analg 84:982–989, 1997.

79. Ross AK, Davis PJ, Dear Gd GL, et al: Pharmacoki-

netics of remifentanil in anesthetized pediatric

patients undergoing elective surgery or diagnostic

procedures. Anesth Analg 93:1393–1401, 2001.

80. Davis PJ, Galinkin J, McGowan FX, et al: A rando-

mized multicenter study of remifentanil compared

with halothane in neonates and infants undergoing

pyloromyotomy. I. Emergence and recovery profiles.

Anesth Analg 93:1380–1386, 2001.

81. Galinkin JL, Davis PJ, McGowan FX, et al: A rando-

mized multicenter study of remifentanil compared

with halothane in neonates and infants undergoing

pyloromyotomy. II. Perioperative breathing patterns

in neonates and infants with pyloric stenosis.

Anesth Analg 93:1387–1392, 2001.

82. Morgan JM, Barker I, Peacock JE, Eissa A: A com-

parison of intubating conditions in children

following induction of anaesthesia with propofol

and suxamethonium or propofol and remifentanil.

Anaesthesia 62:135–139, 2007.

83. Crawford MW, Hayes J, Tan JM: Dose-response of

remifentanil for tracheal intubation in infants.

Anesth Analg 100:1599–1604, 2005.

84. Lovich MA, Kinnealley ME, Sims NM, Peterfreund

RA: The delivery of drugs to patients by continuous

intravenous infusion: Modeling predicts potential

dose fluctuations depending on flow rates and infu-

sion system dead volume. Anesth Analg 102:1147–

1153, 2006.

85. Lovich MA, Doles J, Peterfreund RA: The impact of

carrier flow rate and infusion set dead-volume on

the dynamics of intravenous drug delivery. Anesth

Analg 100:1048–1055, 2005.

86. Munoz HR, Cortinez LI, Altermatt FR, Dagnino JA:

Remifentanil requirements during sevoflurane

administration to block somatic and cardiovascular

responses to skin incision in children and adults.

Anesthesiology 97:1142–1145, 2002.

87. Munoz HR, Cortinez LI, Ibacache ME, Altermatt

FR: Remifentanil requirements during propofol

administration to block the somatic response to

skin incision in children and adults. Anesth Analg

104:77–80, 2007.

88. Stewart JT, Warren FW, Maddox FC, et al: The sta-

bility of remifentanil hydrochloride and propofol

mixtures in polypropylene syringes and polyvinyl-

chloride bags at 22 degrees-24 degrees C. Anesth

Analg 90:1450–1451, 2000.

89. Rosenberg H, Gronert GA: Intractable cardiac

arrest in children given succinylcholine. Anesthe-

siology 77:1054, 1992.

90. Larach MG, Rosenberg H, Gronert GA, Allen GC:

Hyperkalemic cardiac arrest during anesthesia in

infants and children with occult myopathies. Clin

Pediatr (Phila) 36:9–16, 1997.

91. Mazurek AJ, Rae B, Hann S, et al: Rocuronium

versus succinylcholine: Are they equally effective

during rapid-sequence induction of anesthesia?

Anesth Analg 87:1259–1262, 1998.

92. Reynolds LM, Lau M, Brown R, et al: Intramuscular

rocuronium in infants and children. Dose-ranging

and tracheal intubating conditions. Anesthesiology

85:231–239, 1996.

93. Adam JM, Bennett DJ, Bom A, et al: Cyclodextrin-

derived host molecules as reversal agents for the

neuromuscular blocker rocuronium bromide: Syn-

thesis and structure-activity relationships. J Med

Chem 45:1806–1816, 2002.

94. Naguib M: Sugammadex: Another milestone in cli-

nical neuromuscular pharmacology. Anesth Analg

104:575–581, 2007.

95. Gijsenbergh F, Ramael S, Houwing N, van Iersel T:

First human exposure of Org 25969, a novel agent

to reverse the action of rocuronium bromide. Anes-

thesiology 103:695–703, 2005.

96. Hunter JM, Flockton EA: The doughnut and the

hole: A new pharmacological concept for anaesthe-

tists. Br J Anaesth 97:123–126, 2006.

97. de Boer HD, van Egmond J, van de Pol F, et al: Time

course of action of sugammadex (Org 25969) on

rocuronium-induced block in the Rhesus monkey,

using a simple model of equilibration of complex

formation. Br J Anaesth 97:681–686, 2006.

98. Epemolu O, Bom A, Hope F, Mason R: Reversal of

neuromuscular blockade and simultaneous increase

in plasma rocuronium concentration after the

intravenous infusion of the novel reversal agent Org

25969. Anesthesiology 99:632–637, 2003.

99. Shields M, Giovannelli M, Mirakhur RK, et al: Org

25969 (sugammadex), a selective relaxant binding

agent for antagonism of prolonged rocuronium-

induced neuromuscular block. Br J Anaesth 96:36–

43, 2006.

100. Sacan O, White PF, Tufanogullari B, Klein K: Sugam-

madex reversal of rocuronium-induced neuromus-

cular blockade: A comparison with neostigmine-

glycopyrrolate and edrophonium-atropine. Anesth

Analg 104:569–574, 2007.

101. Coté CJ: Preoperative preparation and premedica-

tion. Br J Anaesth 83:16–28, 1999.

102. Practice guidelines for preoperative fasting and the

use of pharmacologic agents to reduce the risk of

pulmonary aspiration: Application to healthy

patients undergoing elective procedures: A report

by the American Society of Anesthesiologist Task

Force on Preoperative Fasting. Anesthesiology

90:896–905, 1999.

103. Gutstein HB, Johnson KL, Heard MB, Gregory GA:

Oral ketamine preanesthetic medication in chil-

dren. Anesthesiology 76:28–33, 1992.

104. Miller BR, Friesen RH: Oral atropine premedication

in infants attenuates cardiovascular depression

during halothane anesthesia. Anesth Analg 67:180–

185, 1988.

105. Tait AR, Malviya S, Voepel-Lewis T, et al: Risk

factors for perioperative adverse respiratory events

in children with upper respiratory tract infections.

Anesthesiology 95:299–306, 2001.

106. Parnis SJ, Barker DS, van der Walt JH: Clinical pre-

dictors of anaesthetic complications in children

with respiratory tract infections. Paediatr Anaesth

11:29–40, 2001.

107. Skolnick ET, Vomvolakis MA, Buck KA, et al: Expo-

sure to environmental tobacco smoke and the risk

of adverse respiratory events in children receiving

general anesthesia. Anesthesiology 88:1144–1153,

1998.

108. Elwood T, Morris W, Martin LD, et al: Bronchodila-

tor premedication does not decrease respiratory

adverse events in pediatric general anesthesia. Can

J Anaesth 50:277–284, 2003.

109. Tait AR, Burke C, Voepel-Lewis T, et al: Glyco-

pyrrolate does not reduce the incidence of perio-

perative adverse events in children with upper

respiratory tract infections. Anesth Analg 104:265–

270, 2007.

110. Empey DW: Effect of airway infections on bron-

chial reactivity. Eur J Respir Dis Suppl 128:366–368,

1983.

111. Rachel HJ, Elwood T, Peterson D, Rampersad S: Risk

factors for adverse events in children with colds

emerging from anesthesia: A logistic regression.

Paediatr Anaesth 17:154–161, 2007.

112. Cohen MM, Cameron CB: Should you cancel the

operation when a child has an upper respiratory

tract infection? Anesth Analg 72:282–288, 1991.

113. Wheeler M: ProSeal laryngeal mask airway in 120

pediatric surgical patients: A prospective evaluation

of characteristics and performance. Paediatr

Anaesth 16:297–301, 2006.

114. Coté CJ, Eavey RD, Todres ID, Jones DE: Crico-

thyroid membrane puncture: Oxygenation and ven-

tilation in a dog model using an intravenous

catheter. Crit Care Med 16:615–619, 1988.

115. Holliday MA, Segar WE: The maintenance need for

water in parenteral fluid therapy. Pediatrics 19:823–

832, 1957.

116. Coté CJ, Zaslavsky A, Downes JJ, et al: Postoperative

apnea in former preterm infants after inguinal her-

niorrhaphy. A combined analysis. Anesthesiology

82:809–822, 1995.

117. Barcelona SL, Thompson AA, Coté CJ: Intraopera-

tive pediatric blood transfusion therapy: A review

of common issues. Part I: Hematologic and physio-

logic differences from adults; metabolic and infec-

tious risks. Paediatr Anaesth 15:716–726, 2005.

Anestesia pediátrica

2361

Sección V

Anestesia pediátrica